173 related articles for article (PubMed ID: 22551917)
1. Congenital vascular malformations--cerebral lesions differ from extracranial lesions by their immune expression of the glucose transporter protein GLUT1.
Meijer-Jorna LB; Aronica E; van der Loos CM; Troost D; van der Wal AC
Clin Neuropathol; 2012; 31(3):135-41. PubMed ID: 22551917
[TBL] [Abstract][Full Text] [Related]
2. Fatty acid binding protein 4 expression in cerebral vascular malformations: implications for vascular remodelling.
Cataltepe S; Arikan MC; Liang X; Smith TW; Cataltepe O
Neuropathol Appl Neurobiol; 2015 Aug; 41(5):646-56. PubMed ID: 24865546
[TBL] [Abstract][Full Text] [Related]
3. Expression of platelet-derived growth factor ligand and receptor in cerebral arteriovenous and cavernous malformations.
Yildirim O; Bicer A; Ozkan A; Kurtkaya O; Cirakoglu B; Kilic T
J Clin Neurosci; 2010 Dec; 17(12):1557-62. PubMed ID: 20822908
[TBL] [Abstract][Full Text] [Related]
4. Gene expression analysis of nidus of cerebral arteriovenous malformations reveals vascular structures with deficient differentiation and maturation.
Thomas JM; Surendran S; Abraham M; Sasankan D; Bhaadri S; Rajavelu A; Kartha CC
PLoS One; 2018; 13(6):e0198617. PubMed ID: 29897969
[TBL] [Abstract][Full Text] [Related]
5. [The expression and role of glucose transporter-1 in infantile hemangioma].
Yuan SM; Jiang HQ; Hong ZJ; Wang J; Hu XB; Ouyang TX; Xing X
Zhonghua Zheng Xing Wai Ke Za Zhi; 2007 Mar; 23(2):90-3. PubMed ID: 17554865
[TBL] [Abstract][Full Text] [Related]
6. Abnormal elastin and collagen deposition is present in extracranial arteriovenous malformations: A comparison to intracranial disease.
Wei T; Shalin S; Draper E; Miller E; Zhang H; Sun R; Lee M; Albert G; Richter GT
Histol Histopathol; 2019 Dec; 34(12):1355-1363. PubMed ID: 31119718
[TBL] [Abstract][Full Text] [Related]
7. Expression of integrins in cerebral arteriovenous and cavernous malformations.
Seker A; Yildirim O; Kurtkaya O; Sav A; Günel M; Pamir MN; Kiliç T
Neurosurgery; 2006 Jan; 58(1):159-68; discussion 159-68. PubMed ID: 16385340
[TBL] [Abstract][Full Text] [Related]
8. CTCFL expression is associated with cerebral vascular abnormalities.
Sati L; Soygur B; Goksu E; Bassorgun CI; McGrath J
Tissue Cell; 2021 Oct; 72():101528. PubMed ID: 33756271
[TBL] [Abstract][Full Text] [Related]
9. GLUT1 endothelial reactivity distinguishes hepatic infantile hemangioma from congenital hepatic vascular malformation with associated capillary proliferation.
Mo JQ; Dimashkieh HH; Bove KE
Hum Pathol; 2004 Feb; 35(2):200-9. PubMed ID: 14991538
[TBL] [Abstract][Full Text] [Related]
10. Vascular smooth muscle cell differentiation in human cerebral vascular malformations.
Uranishi R; Baev NI; Kim JH; Awad IA
Neurosurgery; 2001 Sep; 49(3):671-9; discussion 679-80. PubMed ID: 11523679
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of transmembrane endothelial junction proteins in human cerebral cavernous malformations.
Burkhardt JK; Schmidt D; Schoenauer R; Brokopp C; Agarkova I; Bozinov O; Bertalanffy H; Hoerstrup SP
Neurosurg Focus; 2010 Sep; 29(3):E3. PubMed ID: 20809761
[TBL] [Abstract][Full Text] [Related]
12. Expression of endothelial cell angiogenesis receptors in human cerebrovascular malformations.
Uranishi R; Baev NI; Ng PY; Kim JH; Awad IA
Neurosurgery; 2001 Feb; 48(2):359-67; discussion 367-8. PubMed ID: 11220380
[TBL] [Abstract][Full Text] [Related]
13. DNA fragmentation in central nervous system vascular malformations.
Takagi Y; Hattori I; Nozaki K; Ishikawa M; Hashimoto N
Acta Neurochir (Wien); 2000; 142(9):987-94. PubMed ID: 11086807
[TBL] [Abstract][Full Text] [Related]
14. Intracranial vascular anomalies in patients with periorbital lymphatic and lymphaticovenous malformations.
Bisdorff A; Mulliken JB; Carrico J; Robertson RL; Burrows PE
AJNR Am J Neuroradiol; 2007 Feb; 28(2):335-41. PubMed ID: 17297008
[TBL] [Abstract][Full Text] [Related]
15. Vis-à-vis: a focus on genetic features of cerebral cavernous malformations and brain arteriovenous malformations pathogenesis.
Scimone C; Donato L; Marino S; Alafaci C; D'Angelo R; Sidoti A
Neurol Sci; 2019 Feb; 40(2):243-251. PubMed ID: 30523548
[TBL] [Abstract][Full Text] [Related]
16. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas.
North PE; Waner M; Mizeracki A; Mihm MC
Hum Pathol; 2000 Jan; 31(1):11-22. PubMed ID: 10665907
[TBL] [Abstract][Full Text] [Related]
17. Ephrin B2 and EphB4 selectively mark arterial and venous vessels in cerebral arteriovenous malformation.
Bai J; Wang YJ; Liu L; Zhao YL
J Int Med Res; 2014 Apr; 42(2):405-15. PubMed ID: 24517927
[TBL] [Abstract][Full Text] [Related]
18. Ultrastructural pathological features of cerebrovascular malformations: a preliminary report.
Wong JH; Awad IA; Kim JH
Neurosurgery; 2000 Jun; 46(6):1454-9. PubMed ID: 10834648
[TBL] [Abstract][Full Text] [Related]
19. The utility of GLUT1 as a diagnostic marker in cutaneous vascular anomalies: A review of literature and recommendations for daily practice.
van Vugt LJ; van der Vleuten CJM; Flucke U; Blokx WAM
Pathol Res Pract; 2017 Jun; 213(6):591-597. PubMed ID: 28552538
[TBL] [Abstract][Full Text] [Related]
20. [Clinicopathologic study of pediatric vascular anomalies: a report of 117 cases].
Niu HL; Zhou SY; Lin QQ; Yi P; Wang FH; Gao Q; Chen ZR; Xia JQ; Zheng HC; Zeng RX
Zhonghua Bing Li Xue Za Zhi; 2016 Apr; 45(4):252-7. PubMed ID: 27033389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
